ENTRY       D11799                      Drug
NAME        Bentracimab (USAN)
FORMULA     C2095H3240N560O674S12
EXACT_MASS  47411.3119
MOL_WEIGHT  47440.2697
SEQUENCE    (Heavy chain)
            QVQLQESGAE VKKPGSSVRV SCKASGGTFD SYSIHWVRQA PGQGLEWMGG IIPAFGTLSS
            AQDFQARVTI SADKSTSTAY MELSGLRSED TAVYYCARGS FDYYFWSASH PPNDALAIWG
            QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH
            TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKRVEPK SCDK
            (Light chain)
            QSVVTQPPSV SAAPGQKVTI SCSGSNSDIG NNYVSWYQQL PGTAPKLLIY DNNKRPSGIP
            DRFSGSKSGT SATLAITGLQ AGDEADYYCG TWLYDRAVGL FGGGTKVTVL GQPKAAPSVT
            LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADSSPVK AGVETTTPSK QSNNKYAASS
            YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
            (Disulfide bridge: H22-H96, H156-H212, H232-L215, L22-L89, L138-L197)
  TYPE      Peptide
EFFICACY    Hemostatic, Reversal agent (ticagrelor)
  TYPE      Monoclonal antibody
COMMENT     Agent for reversing the antiplatelet effects of ticagrelor [DR:D09017]
TARGET      Ticagrelor [DR:D09017]
DBLINKS     CAS: 2260568-31-6
            PubChem: 405226665
///
